486 related articles for article (PubMed ID: 24812504)
1. Cytokine inhibition in the treatment of COPD.
Caramori G; Adcock IM; Di Stefano A; Chung KF
Int J Chron Obstruct Pulmon Dis; 2014; 9():397-412. PubMed ID: 24812504
[TBL] [Abstract][Full Text] [Related]
2. Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD.
Calderon AA; Dimond C; Choy DF; Pappu R; Grimbaldeston MA; Mohan D; Chung KF
Eur Respir Rev; 2023 Mar; 32(167):. PubMed ID: 36697211
[TBL] [Abstract][Full Text] [Related]
3. Constitutive and inducible thymic stromal lymphopoietin expression in human airway smooth muscle cells: role in chronic obstructive pulmonary disease.
Zhang K; Shan L; Rahman MS; Unruh H; Halayko AJ; Gounni AS
Am J Physiol Lung Cell Mol Physiol; 2007 Aug; 293(2):L375-82. PubMed ID: 17513456
[TBL] [Abstract][Full Text] [Related]
4. Thymic stromal lymphopoietin (TSLP) and Toluene-diisocyanate-induced airway inflammation: Alleviation by TSLP neutralizing antibody.
Yu G; Zhang Y; Wang X; Sai L; Bo C; Yeo AJ; Lavin MF; Peng C; Jia Q; Shao H
Toxicol Lett; 2019 Dec; 317():59-67. PubMed ID: 31577921
[TBL] [Abstract][Full Text] [Related]
5. Canakinumab for the treatment of chronic obstructive pulmonary disease.
Rogliani P; Calzetta L; Ora J; Matera MG
Pulm Pharmacol Ther; 2015 Apr; 31():15-27. PubMed ID: 25660162
[TBL] [Abstract][Full Text] [Related]
6. IL-17 Aggravates
Ding F; Han L; Fu Q; Fan X; Tang R; Lv C; Xue Y; Tian X; Zhang M
Front Immunol; 2021; 12():811803. PubMed ID: 35095906
[No Abstract] [Full Text] [Related]
7. Targeting IL-5 in COPD.
Narendra DK; Hanania NA
Int J Chron Obstruct Pulmon Dis; 2019; 14():1045-1051. PubMed ID: 31190789
[TBL] [Abstract][Full Text] [Related]
8. Targeting cytokines to treat asthma and chronic obstructive pulmonary disease.
Barnes PJ
Nat Rev Immunol; 2018 Jul; 18(7):454-466. PubMed ID: 29626211
[TBL] [Abstract][Full Text] [Related]
9. Agents against cytokine synthesis or receptors.
Yamagata T; Ichinose M
Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
[TBL] [Abstract][Full Text] [Related]
10. Viral stimuli trigger exaggerated thymic stromal lymphopoietin expression by chronic obstructive pulmonary disease epithelium: role of endosomal TLR3 and cytosolic RIG-I-like helicases.
Calvén J; Yudina Y; Hallgren O; Westergren-Thorsson G; Davies DE; Brandelius A; Uller L
J Innate Immun; 2012; 4(1):86-99. PubMed ID: 21691053
[TBL] [Abstract][Full Text] [Related]
11. Emerging pharmaceutical therapies for COPD.
Lakshmi SP; Reddy AT; Reddy RC
Int J Chron Obstruct Pulmon Dis; 2017; 12():2141-2156. PubMed ID: 28790817
[TBL] [Abstract][Full Text] [Related]
12. Perspectives for cytokine antagonist therapy in COPD.
de Boer WI
Drug Discov Today; 2005 Jan; 10(2):93-106. PubMed ID: 15718158
[TBL] [Abstract][Full Text] [Related]
13. Eosinophil and T cell markers predict functional decline in COPD patients.
D'Armiento JM; Scharf SM; Roth MD; Connett JE; Ghio A; Sternberg D; Goldin JG; Louis TA; Mao JT; O'Connor GT; Ramsdell JW; Ries AL; Schluger NW; Sciurba FC; Skeans MA; Voelker H; Walter RE; Wendt CH; Weinmann GG; Wise RA; Foronjy RF
Respir Res; 2009 Nov; 10(1):113. PubMed ID: 19925666
[TBL] [Abstract][Full Text] [Related]
14. Targeting Cytokines as Evolving Treatment Strategies in Chronic Inflammatory Airway Diseases.
Garth J; Barnes JW; Krick S
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380761
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow mesenchymal stem cells ameliorate lung injury through anti-inflammatory and antibacterial effect in COPD mice.
Liu HM; Liu YT; Zhang J; Ma LJ
J Huazhong Univ Sci Technolog Med Sci; 2017 Aug; 37(4):496-504. PubMed ID: 28786060
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory Kinetics and Efficacy of Anti-inflammatory Treatments on Human Nucleus Pulposus Cells.
Walter BA; Purmessur D; Likhitpanichkul M; Weinberg A; Cho SK; Qureshi SA; Hecht AC; Iatridis JC
Spine (Phila Pa 1976); 2015 Jul; 40(13):955-63. PubMed ID: 25893355
[TBL] [Abstract][Full Text] [Related]
17. Cytokines as targets in chronic obstructive pulmonary disease.
Chung KF
Curr Drug Targets; 2006 Jun; 7(6):675-81. PubMed ID: 16787167
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes.
Barnes PJ
J Allergy Clin Immunol; 2015 Sep; 136(3):531-45. PubMed ID: 26343937
[TBL] [Abstract][Full Text] [Related]
19. Ethanol extract of the tuber of Alisma orientale reduces the pathologic features in a chronic obstructive pulmonary disease mouse model.
Kim KH; Song HH; Ahn KS; Oh SR; Sadikot RT; Joo M
J Ethnopharmacol; 2016 Jul; 188():21-30. PubMed ID: 27154406
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition by simvastatin of IRF3 phosphorylation and TSLP production in dsRNA-challenged bronchial epithelial cells from COPD donors.
Brandelius A; Mahmutovic Persson I; Calvén J; Bjermer L; Persson CG; Andersson M; Uller L
Br J Pharmacol; 2013 Jan; 168(2):363-74. PubMed ID: 22881993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
